PCSK9 and fatty liver disease: Moreover, Lebeau et al. [34] demonstrated that diet-induced hepatic steatosis elevated circulating PCSK9 concentrations as a result of de novo expression in mice by abrogating hepatic low-density lipoprotein receptor expression.